Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes
- PMID: 18594062
- PMCID: PMC2453684
- DOI: 10.2337/dc08-0575
Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes
Abstract
Objective: To determine the time course of changes in glucagon and insulin secretion in children with recently diagnosed type 1 diabetes.
Research design and methods: Glucagon and C-peptide concentrations were determined in response to standard mixed meals in 23 patients with type 1 diabetes aged 9.4 +/- 4.6 years, beginning within 6 weeks of diagnosis, and every 3 months thereafter for 1 year.
Results: Glucagon secretion in response to a physiologic stimulus (mixed meal) increased by 37% over 12 months, while C-peptide secretion declined by 45%. Fasting glucagon concentrations remained within the normal (nondiabetic) reference range.
Conclusions: Postprandial hyperglucagonemia worsens significantly during the first year after diagnosis of type 1 diabetes and may represent a distinct therapeutic target. Fasting glucagon values may underestimate the severity of hyperglucagonemia. The opposing directions of abnormal glucagon and C-peptide secretion over time support the link between dysregulated glucagon secretion and declining beta-cell function.
Figures
Similar articles
-
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.Diabetes Care. 1995 Nov;18(11):1452-9. doi: 10.2337/diacare.18.11.1452. Diabetes Care. 1995. PMID: 8722069
-
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13. doi: 10.1210/jc.2002-021873. J Clin Endocrinol Metab. 2003. PMID: 12788877
-
Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.Diabetes. 2002 Apr;51(4):951-7. doi: 10.2337/diabetes.51.4.951. Diabetes. 2002. PMID: 11916912 Clinical Trial.
-
Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.Diabetes Metab. 1996 Dec;22(6):397-406. Diabetes Metab. 1996. PMID: 8985647 Review.
-
Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.Am J Med. 1985 Aug 23;79(2B):2-5. doi: 10.1016/0002-9343(85)90578-9. Am J Med. 1985. PMID: 3898829 Review.
Cited by
-
Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study.Diabetologia. 2012 Dec;55(12):3359-68. doi: 10.1007/s00125-012-2719-6. Epub 2012 Sep 20. Diabetologia. 2012. PMID: 22990715 Free PMC article.
-
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.Endocrinology. 2012 Mar;153(3):1039-48. doi: 10.1210/en.2011-1499. Epub 2011 Dec 13. Endocrinology. 2012. PMID: 22166985 Free PMC article. Review.
-
Morphological assessment of pancreatic islet hormone content following aerobic exercise training in rats with poorly controlled Type 1 diabetes mellitus.Islets. 2014;6(2):e29221. doi: 10.4161/isl.29221. Islets. 2014. PMID: 25483959 Free PMC article.
-
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.PLoS One. 2014 May 23;9(5):e97143. doi: 10.1371/journal.pone.0097143. eCollection 2014. PLoS One. 2014. PMID: 24858952 Free PMC article. Clinical Trial.
-
Postprandial metabolic effects of fructose and glucose in type 1 diabetes patients: a pilot randomized crossover clinical trial.Arch Endocrinol Metab. 2019 Jul 29;63(4):376-384. doi: 10.20945/2359-3997000000148. Arch Endocrinol Metab. 2019. PMID: 31365624 Free PMC article. Clinical Trial.
References
-
- Gromada J, Franklin I, Wollheim CB: Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84–116, 2007 - PubMed
-
- Sperling MA, Aleck K, Voina S: Suppressibility of glucagon secretion by glucose in juvenile diabetes. J Pediatr 90:543–547, 1977 - PubMed
-
- Gerich JE, Lorenzi M, Karam JH, Schneider V, Forsham PH: Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. JAMA 234:159–155, 1975 - PubMed
-
- Ternand C, Go VL, Gerich JE, Haymond MW: Endocrine pancreatic response of children with onset of insulin-requiring diabetes before age 3 and after age 5. J Pediatr 101:36–39, 1982 - PubMed
-
- Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M: Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Metabolism 54:1168–1173, 2005 - PubMed